While the overall landscape of vaccination rates has not changed (~1.5 million/day), the Biden Administration took several steps this week aimed at increasing that rate in the weeks to come. The administration announced the purchase of an additional 200 million doses (100 million from Pfizer/BioNTech and 100 million from Moderna) for delivery by the end of July.
The Federal Retail Pharmacy Program for COVID-19 Vaccination kicked off this week to provide shots at retain chain pharmacies for individuals who are eligible according to their states prioritization frameworks. Federally Qualified Community Health Centers will begin to directly receive vaccine doses for the populations they serve starting next week. This is part of the administration’s efforts to reduce disparities in the vaccination roll out. To that end, the White House announced new non-federal members to the COVID-19 Equity Task Force. Of note, this included Andrew Imparato who is currently the Executive Director of Disability Rights California and was the lead disability counsel for the HELP Committee under Chairman Harkin.
On the treatment front, FDA issued Eli Lilly an Emergency Use Authorization for the monoclonal antibody combination bamlanivimab and etesevimab.